Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1.
Birch pollen allergy is a very frequent pathology in Europe and North America. More than 95% of the tree pollen allergic patients display IgE reactivity against Bet v 1, the major birch pollen allergen. Starting with PBL from a patient desensitized by immunotherapy, we have generated five B cell lin...
Main Authors: | Visco, V, Dolecek, C, Denépoux, S, Le Mao, J, Guret, C, Rousset, F, Guinnepain, M, Kraft, D, Valenta, R, Weyer, A, Banchereau, J, Labecque, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1996
|
Similar Items
-
Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1.
by: Lebecque, S, et al.
Published: (1997) -
CHARACTERIZATION OF HUMAN MONOCLONAL ANTI-BET-V-I ANTIBODIES WHICH AFFECT THE HUMAN IGE-BINDING TO BET-V-I
by: Lebecque, S, et al.
Published: (1995) -
Mapping of the IgE and IgG binding sites of the major timothy grass pollen allergen Phl p 2 by gene fragmentation
by: Valenta, R, et al.
Published: (1996) -
Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG<sub>1</sub> and IgG<sub>4</sub> against the Major Birch Pollen Allergen Bet v 1
by: Verena K. Köhler, et al.
Published: (2020-08-01) -
Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen.
by: Menz, G, et al.
Published: (1996)